86.90.E - Other human health activities notelsewhere classified
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
63.12.Z - Web portals
63.99.Z - Other information service activities not elsewhere classified
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | -0,3 | 0,1 | 0 | -88,1 |
EBITDA | -0,3 | 0,2 | 0 | -72,5 |
Short time liabilities | 3,5 | 0,7 | 0,2 | -74,1 |
Equity capital | 0 | 0,2 | 0,2 | 9,2 |
Operating profit (EBIT) | -0,3 | 0,1 | 0 | -85,2 |
Assets | 3,5 | 0,8 | 0,4 | -57,1 |
Net profit (loss) | -0,3 | 0,1 | 0 | -88,1 |
Cash | 0,8 | 0,3 | 0 | -95,9 |
Liabilities and provisions for liabilities | 3,5 | 0,7 | 0,2 | -74,1 |
Net income from sale | 22,2 | 7,2 | 0,9 | -87,6 |
Working assets | 3,5 | 0,8 | 0,3 | -57,3 |
Other income costs | ||||
Depreciation | 0 | 0 | 0 | 163,9 |
% | % | % | p.p. | |
Profitability of capital | -709,7 | 77,2 | 8,4 | -68,8 |
Equity capital to total assets | 1,2 | 20,4 | 51,9 | 31,5 |
Gross profit margin | -1,4 | 1,8 | 1,7 | -0,1 |
EBITDA Margin | -1,4 | 2,1 | 4,7 | 2,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 58 | 33 | 70 | 37 |
Current financial liquidity indicator | 1.0104024410247803 | 1.2557458877563477 | 2.0687944889068604 | 0,8 |
Net dept to EBITDA | 2.4726810455322266 | -2.1455881595611572 | -0.32204124331474304 | 1,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane